Antler Bio, an agtech startup that has developed an advanced data analytics system for bovine health, has raised $4.3m (£3.1m) to scale its EpiHerd technology.
Operating in key European dairy farming markets including the UK, Finland, Sweden and Demark, the company’s EpiHerd system can interpret how a cow’s genes respond to environmental conditions, detecting things like stress and nutritional imbalances.
By better understanding the condition of their cattle, farmers can take proactive measures to improve their wellbeing and increase their milk yield.
“Bringing a technology like EpiHerd to an industry that has never seen anything quite like it is no small task, but we’re incredibly excited about the future,” said Antler Bio co-founder and chief executive Maria Jensen.
“This investment will enable us to scale EpiHerd to thousands of farms across Europe, grow our team, and continue refining the technology to meet the evolving needs of farmers, benefiting their profits but, importantly, the wellbeing of their animals.”
The investment came from The First Thirty Ventures along with Endgame Capital and Generation-RE.
“Our investment strategy backs world-class companies creating value where agriculture meets human health. Antler Bio is a great example, combining biology and technology to help reshape the global food system,” added Naeem Lakhani, managing partner at The First Thirty.
“Their work supports animal welfare, enhances farm efficiency, and leads to improved nutrition for consumers. As a company at the forefront of this change, we’re proud to support their journey.”
The latest investment brings the total amount raised by the company to £6.2m.
Register for Free
Bookmark your favorite posts, get daily updates, and enjoy an ad-reduced experience.
Already have an account? Log in
